Speakers:
1. dr. Kartika Widayati, Sp.PD-KHOM from Gadjah Mada University, Indonesia
2. dr. Susanna Hilda Hutajulu, Ph.D., SpPD-KHOM from RSUP Dr. Sardjito, Indonesia
3. dr. Ery Kus Dwianingsih, Ph.D., Dp.PA(K) from RSU Dr. Soeradji Tirtonegoro, Indonesia
4. dr. Johan Kurnianda, Sp.PD-KHOM as Head of PERHOMPEDIN (Indonesian Medical Oncology Medical Oncology Doctors Association) Jogjakarta, Indonesia
New marketing authorization for indication locally advanced unresectable or metastatic pancreatic cancer is approved in Myanmar by the Myanmar FDA. This indication…
Tokyo, Japan (April 25, 2013) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the first patient has been enrolled in…
On 18 Sep 2020, Philippines FDA approved new marketing authorization for indication locally advanced unresectable or metastatic pancreatic cancer for nimotuzumab. This…
Speakers: 1. Prof. Iyer Narayanan Gopalakrishna, Head and neck surgeon in National Cancer Centre and Singapore General Hospital 2. Prof. Dr. Kumar…
Medical Oncology Group of Australia